Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis-Reference-Cited by-同舟云学术

Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis

Published:1990-07-13 Issue:4965 Volume:249 Page:146-151
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Weisman Harlan F.¹,Bartow Thomas¹,Leppo Michelle K.¹,Marsh Henry C.²,Carson Gerald R.²,Concino Michael F.²,Boyle Michael P.¹,Roux Kenneth H.³,Weisfeldt Myron L.¹,Fearon Douglas T.¹

Affiliation:

1. Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.

2. T Cell Sciences, Inc., Cambridge, MA 02139

3. Department of Biological Sciences, Florida State University, Tallahassee, FL 32306.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference65 articles.

1. LANCET 2: 349 (1988).

2. AMBROSIO, G, PROGRESSIVE IMPAIRMENT OF REGIONAL MYOCARDIAL PERFUSION AFTER INITIAL RESTORATION OF POSTISCHEMIC BLOOD-FLOW, CIRCULATION 80: 1846 (1989).

3. ARNAOUT, M.A., DEFICIENCY OF A LEUKOCYTE SURFACE GLYCOPROTEIN (LFA-1) IN 2 PATIENTS WITH MO1 DEFICIENCY - EFFECTS OF CELL ACTIVATION ON MO1 LFA-1 SURFACE EXPRESSION IN NORMAL AND DEFICIENT LEUKOCYTES, JOURNAL OF CLINICAL INVESTIGATION 74: 1291 (1984).

4. BECKER, L.C., MYOCARDIAL CONSEQUENCES OF REPERFUSION, PROGRESS IN CARDIOVASCULAR DISEASES 30: 23 (1987).

5. BIESECKER, G, INHIBITION OF ACUTE PASSIVE TRANSFER EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS WITH FAB ANTIBODY TO COMPLEMENT C6, JOURNAL OF IMMUNOLOGY 142: 2654 (1989).

Cited by 936 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation;Blood Advances;2024-08-02

2. Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis;Frontiers in Immunology;2024-07-11

3. Mechanistic insights into complement pathway inhibition by CR1 domain duplication;Journal of Biological Chemistry;2024-07

4. Complement-pentraxins synergy: Navigating the immune battlefield and beyond;Biomedicine & Pharmacotherapy;2023-12

5. The Molecular Mechanisms of Complement Receptor 1—It Is Complicated;Biomolecules;2023-10-13